activesellsec_filings

RTX 10-Q report for 2026-03-31

RTX Corporation filed its Form 10‑Q for the quarter ended March 31, 2026. The filing includes condensed consolidated financial statements (statement of operations, comprehensive income, balance sheet, cash flows, changes in equity), selected notes (goodwill, intangibles, EPS, contract estimates), MD&A table of contents and risk/other items. This play documents the filing and provides the primary reported metrics for the quarter.

Confidence
60 / 100
Assets
1
Authors
1
Outcome
open

Linked assets

RTX (RTX) — aerospace & defense conglomerate with three reportable segments: Collins Aerospace, Pratt & Whitney and Raytheon. The 10‑Q contains quarter-to-quarter operating results, balance sheet and cash flow metrics, and supplemental notes relevant to revenue recognition and contract estimates.

RTXRTX Corporationsellopen

RTX Corporation, an aerospace and defense company, provides systems and services for commercial, military, and government customers worldwide.

Confidence: 60 / 100Start: $187.17Latest: $179.44Return: 4.13%

The Form 10‑Q filed for the quarter ended March 31, 2026 provides unaudited condensed consolidated financial statements and notes. Reported highlights include: total net sales $22,076 million (Q1 2026) vs $20,306 million (Q1 2025); operating profit $2,555 million; net income attributable to common shareowners $2,059 million; diluted EPS $1.51; cash and cash equivalents $6,818 million; total assets $170,431 million and total liabilities $102,397 million as of March 31, 2026. The filing also includes MD&A, market risk disclosures, and notes on goodwill, intangible assets, EPS, and contract estimates. Use these reported line items as the official quarter reference; the filing alone does not constitute a specific buy/sell signal without further context and market information.

Source proof

Source proof: Strong source proof | 1 directional asset | 1 supporting author | headline-like title review

Primary source: RTX Corporation Form 10‑Q for the quarter ended March 31, 2026 (SEC filing, Commission file number 001-00812). The filing includes unaudited condensed consolidated statements and accompanying notes, plus Part II disclosures and exhibits.

SNBR 10-Q report for 2026-04-04
Sleep Number Corp · May 12, 2026, 3:06 AM EDT

This excerpt is only the cover page/header of Sleep Number’s Form 10-Q for the quarter ended April 4, 2026. It contains filing metadata (issuer, ticker, exchange, address) but no financial statements, MD&A, guidance, risks, or operational commentary. As a result, it is not directly actionable for trading beyond confirming the filing exists.

View source
SOUN 10-Q report for 2026-03-31
SOUNDHOUND AI, INC. · May 11, 2026, 5:28 PM EDT

The provided excerpt is only the cover/filing header of SoundHound AI, Inc.’s 10‑Q for the quarter ended 2026‑03‑31. It contains listing/security identifiers (SOUN, SOUNW) but no financial statements, MD&A, guidance, risk updates, liquidity details, or material events. As a result, there is insufficient information to form high-confidence, actionable bullish/bearish theses beyond generic “company filed its 10‑Q” metadata.

View source
WEAT 10-Q report for 2026-03-31
Teucrium Commodity Trust · May 11, 2026, 5:19 PM EDT

The provided excerpt is only the boilerplate cover/filing-status section of Teucrium Commodity Trust’s Form 10‑Q for period ended 2026‑03‑31, with no portfolio holdings, performance, risk, or material updates included. As-is, it contains no actionable investment information beyond confirming the existence of the filing and the issuer/ticker identity (WEAT).

View source
ACHR 10-Q report for 2026-03-31
Archer Aviation Inc. · May 11, 2026, 5:01 PM EDT

This excerpt is essentially the cover page of Archer Aviation’s Form 10‑Q for the quarter ended 2026‑03‑31 (issuer identity, exchange listing, and securities outstanding). It contains no operating/financial results, guidance, liquidity details, backlog, or risk-factor updates—so it is minimally actionable for trading beyond basic security identifiers and a generic dilution/optionality consideration from warrants.

View source
CLSK 10-Q report for 2026-03-31
CLEANSPARK, INC. · May 11, 2026, 4:58 PM EDT

This excerpt is essentially the cover page of CleanSpark, Inc.’s Form 10-Q for the quarter ended March 31, 2026. It contains identifiers (CIK/file no.), listing venue, and security descriptions (common stock and redeemable warrants with specific exercise terms), but no operating/financial results, guidance, risks, or MD&A detail. Actionability is therefore limited to capital-structure/dilution considerations around the listed warrant.

View source
ASTS 10-Q report for 2026-03-31
AST SpaceMobile, Inc. · May 11, 2026, 4:40 PM EDT

This excerpt of AST SpaceMobile’s 10‑Q is largely SEC cover-page/boilerplate (registrant info, exchange listing, filing compliance) and contains no financial results, guidance, liquidity, risk-factor updates, or operating metrics. As provided, it does not create a clear tradable catalyst beyond confirming continued reporting/listing status.

View source
SMCI 10-Q report for 2026-03-31
Super Micro Computer, Inc. · May 11, 2026, 4:38 PM EDT

This excerpt only includes the cover page of Super Micro Computer, Inc.’s Form 10‑Q for the quarter ended March 31, 2026. It confirms the filing, issuer identity, listing (Nasdaq), and ticker (SMCI), but contains no financial results, guidance, risks, or MD&A content to support a directional investment view.

View source
ABCL 10-Q report for 2026-03-31
AbCellera Biologics Inc. · May 11, 2026, 4:18 PM EDT

The provided text is only the cover/header portion of AbCellera Biologics Inc.’s Form 10‑Q for the quarter ended March 31, 2026 (identifying info, exchange listing, filing status). It contains no financial statements, guidance, risk updates, material events, MD&A, cash runway, pipeline/program updates, or disclosures that would support a differentiated trading view.

View source

Supporting authors

Prepared from the company’s filed Form 10‑Q. Analysis bundle includes related SEC cover-page excerpts from other companies’ 10‑Qs that are limited to filing headers and not directly actionable.

Unlock full thesis monitoring

Review the 10‑Q for line-item details (revenue by segment, contract assets/liabilities, debt maturities, pension and hedging disclosures) before acting. For trading decisions, supplement with latest guidance, analyst models and market prices.